Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
100
NCT05490225
Access Cannulation Trial II
Phase: N/A
Role: Lead Sponsor
Start: Apr 23, 2025
Completion: Mar 25, 2027